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Often, cholestatic jaundice caused by intrahepatic hepatocellular 
disease may be clinically and biochemically indistinguishable 
from cholestasis due to extrahepatic bile duct obstruction.  The 
most common intrahepatic causes of jaundice are viral hepatitis, 
alcohol-induced hepatitis, cirrhosis and drug-induced jaundice. 
Extrahepatic jaundice is most often due to a stone in the common 
bile duct (CBD) or a pancreaticobiliary malignancy (pancreatic, 
ampullary or cholangiocarcinoma). Pancreatic pseudocysts, 
chronic pancreatitis, sclerosing cholangitis, benign bile duct 
strictures or parasites in the bile duct are less common causes.
The principal clinical task is to distinguish obstructive jaundice 
from jaundice due to parenchymal liver disease.  If major bile 
ducts are obstructed, surgery or therapeutic endoscopy may be 
required, but should be avoided in parenchymal liver disease as 
inappropriate intervention may aggravat the situation. In most 
patients, a likely cause of jaundice can often be established by taking 
a careful history, completing a thorough physical examination, 
testing the urine and stool, and requesting basic haematology and 
liver function tests, including viral serology (Table I). These easily 
obtained blood tests may confirm the initial clinical diagnosis or 
refine the differential diagnosis and direct further appropriate 
investigations.  Since most jaundiced patients are not critically ill 
when initially assessed, diagnosis and therapy can be undertaken 
in a stepwise fashion, with each subsequent test logically selected 
according to the information available at that point. Only severe or 
worsening cholangitis requires urgent intervention. 
Over the past decade technical advances in imaging equipment 
have significantly modified the investigation of biliary tract 
diseases. A wide array of special investigations, including 
expensive and invasive procedures, is now available for evaluating 
the jaundiced patient with suspected biliary obstruction. Complete 
assessment of biliary obstruction requires detailed imaging to 
define the exact level and cause of the biliary obstruction, and to 
implement treatment.  Currently available technologies include 
transabdominal ultrasonography (US), endoscopic retrograde 
cholangiopancreatography (ERCP), percutaneous transhepatic 
cholangiography (PTC), endoscopic ultrasound (EUS), magnetic 
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Table I.  First steps in the diagnosis of jaundice
•    Clinical history
•    Physical examination
•    Urine examination
•    Stool examination
•    Biochemistry
•    Bilirubin
•    Alkaline phosphatase
•    Gamma GT
•    Transaminases
•    Haematology
•    Haemoglobin
•    WBC
•    Platelets
•    INR
•    Viral markers
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resonance imaging with cholangio-
pancreatography (MRI,  MRCP) and 
helical (or spiral) computed tomography 
(CT). Direct imaging techniques such as 
ERCP and PTC are invasive and carry a 
higher associated risk, but have the added 
ability to sample tissue and perform biliary 
drainage with stenting or stone removal. 
Indirect techniques offer lower procedural 
risk and permit staging of malignancies. 
New direct radiological investigations 
such as MRCP (often together with 
solid-organ MRI), EUS, and spiral CT 
provide improved imaging quality at 
low risk.  However, without a clear and 
rational strategy, the inappropriate use 
of imaging may lead to the duplication 
of investigations with resultant increased 
costs, delayed diagnosis and, possibly, 
unwarranted morbidity.  
Initial imaging in 
obstructive jaundice
Radiological imaging is the cornerstone 
of diagnosis in patients with suspected 
extrahepatic obstructive jaundice. Several 
algorithmic approaches have been des-
cribed, all starting with an ultrasound 
scan (Fig.1). If dilated ducts are seen on 
ultrasound, referral to a specialist with 
experience in hepatobiliary disease is wise, 
as endoscopic or surgical intervention may 
be required.  Accurate information about 
the level of biliary obstruction is essential 
because therapy may be complex with 
hilar obstructions, and these patients are 




Abdominal US is the initial imaging test 
of choice in jaundiced patients because it 
is non-invasive, inexpensive and readily 
available.  US is highly operator dependent 
and requires skill and experience to 
produce consistently good results. Dilated 
ducts are indirect evidence of biliary 
obstruction. As a rough guide, a CBD of 
less than 7 mm internal transverse diameter 
is regarded as normal, while a larger 
diameter suggests biliary obstruction. 
US is particularly useful because it offers 
the ability to assess pancreaticobiliary 
structures non-invasively and in real-time 
without exposing the patient to ionising 
radiation.  A definitive diagnosis can be 
made by demonstrating gallstones in 
the gallbladder or CBD, or a mass in the 
head of the pancreas.  In patients without 
dilated ducts, hepatocellular disease is the 
likely diagnosis; however, parenchymal 
liver disease or sclerosing cholangitis 
may prevent biliary dilatation despite 
obstruction being present.  
Other than being nil per mouth little 
preparation is required, so the procedure is 
generally well tolerated. As new-generation 
US scanners are compact and self-
contained, the equipment can be wheeled 
to the patient in the ward, the ICU or the 
operating theatre. A unique application of 
US is colour Doppler imaging that can be 
used to assess the patency, direction and 
volume of blood flow in critical vessels 
such as the portal, superior mesenteric 
and hepatic veins, and hepatic artery.  
Although US is widely used, there are 
important limitations.  The clearest images 
are obtained in lean patients because 
resolution deteriorates with depth and 
obesity; bone and gas are impenetrable 
and further limit visibility. 
Computed tomo graphy 
(CT) scanning 
CT technology has improved significantly 
over the past two decades (Fig. 2). The 
evolution has proceeded through several 
stages, from conventional CT to helical 
(or spiral) CT to new, multidetector CT 
in which ultrafast detector rotation and 
collimation can be combined to yield 
high-resolution, three-dimensional 
reconstructions of the liver, pancreas and 
related structures with excellent vascular 
enhancement.
Spiral CT after intravenous injection of 
iodinated contrast medium allows the 
rapid acquisition of images during the 
arterial, portal, and delayed parenchymal 
phases. It also provides high-quality, three-
dimensional reconstructions in various 
formats and can depict up to third-order 
intrahepatic branches.
These advances in technology have 
expanded the role of CT in evaluating 
the biliary tree. The high-resolution, 
thin-slice images in single breath-holds, 
and the ability to display these images in 
cine mode and coronal views are ideal 
for tracing the dilated bile ducts to the 
point of obstruction. CT scanning is also 
helpful in evaluating liver masses, often 
complementing US. CT is now widely 
accepted as the imaging method of choice 
to detect, stage, and assess resectability of 
pancreatic tumours. 
The major advantages of spiral CT 
over ERCP or EUS include its low 
level of invasiveness, minimal operator 
dependence, low technical failure rate and, 
in contrast to ERCP, ability to produce a 
three-dimensional image of the biliary 
tree.  The major limitations of CT are 
the inability to detect small peritoneal 
implants, small hepatic metastases, lymph 
node metastasis in normal-sized nodes, 
and intraductal tumour extent.  Spiral CT 
gives a relatively high dose of radiation to 
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Referral to HPB Specialist
Intrahepatic dilatation only:




pancreatic or distal cholangiocarcinoma
CT / MRCP with PTC ERCP
Fig. 1. Algorithmic approach to imaging in obstructive jaundice.
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patients and a further drawback is a small 
risk of adverse reaction to the iodinated 
contrast agents. Its main limitation is in 
patients with impaired renal function with 
high serum creatinine levels, as contrast 
may be nephrotoxic.  Artefacts produced 
by patient movement, respiration and 




MRI is the most recent advance in cross-
sectional imaging of the bile ducts and 
liver. The physics of MRI is complex and 
uses magnetic fields and radiowaves 
to chart the regional density of mobile 
hydrogen nuclei in the body.  Although 
spiral CT is usually the first choice in 
cross-sectional imaging of the liver and 
pancreas, MRI is rapidly evolving in the 
evaluation of the patient with pancreatic 
cancer as a ‘one-stop shop’.  MRI is also 
useful in patients with contrast allergy 
or in those with reduced renal function, 




This technique involves the manipulation 
of a volume of data acquired by MRI. A 
heavily T2-weighted sequence enhances 
the signal of ‘water-filled’ bile and 
pancreatic ducts without the use of 
contrast material or ionising radiation, 
to produce high-quality images of ductal 
anatomy (Fig. 3).
MRCP is accurate in demonstrating the 
presence and level of biliary obstruction, 
but is less sensitive for detecting small 
stones.  The major advantage of MRCP is 
the non-invasive nature of the procedure. 
It usually does not require conscious 
sedation and, in contrast to ERCP, MRCP 
can demonstrate the biliary tree above 
and below complete obstructions.  In 
cholangiocarcinoma, the main advantage 
of MRCP is that it can non-invasively 
provide a three-dimensional image of the 
biliary tree, which can help in planning 
treatment.  The major disadvantages of 
MRCP compared with ERCP are lower 
resolution, unit availability, lack of any 
immediate therapy for duct obstruction, 
claustrophobia, and the inability to 





ERCP is regarded as the gold standard for 
imaging the biliary system and combines 
the advantage of diagnosis of biliary 
obstruction with therapeutic intervention, 
if required. ERCP is the intervention of 
choice in patients with CBD stones and in the 
palliation of malignant biliary obstruction 
(Figs 4 - 6). The drawbacks of ERCP 
include high equipment costs, the need 
for conscious sedation, and dependence 
on skilled interventional endoscopists. 
The failure rate increases substantially 
in patients with altered anatomy, such 
as after a Billroth II gastrectomy, or in 
patients with duodenal narrowing due to 
tumour infiltration.  Stenting a proximal 
hilar cholangiocarcinoma can be difficult, 
and undrained contrast injection above 
the site of obstruction usually mandates 
urgent PTC biliary drainage because of 
the risk of cholangitis.  The most common 
complications after ERCP are acute 
pancreatitis and cholangitis, which are 
severe in 1% of patients.  Because of these 
risks and the availability of MRCP, ERCP is 




PTC involves puncture, under local 
anaesthesia, of either the left or right 
liver lobe with a fine flexible needle 
using fluoroscopic guidance to enter a 
peripheral intrahepatic bile duct.  Contrast 
is injected to outline the biliary system 
and identify the obstruction.  A skilled 
interventional radiologist can successfully 
opacify the intrahepatic biliary tree in 
nearly all patients with dilated ducts, and 
in most patients with non-dilated ducts 
(Fig. 7). The overall procedure morbidity 
is less than 5%.  Possible complications 
include bleeding, bile leaks, cholangitis, 
septicaemia, pneumothorax, and rarely 
allergic reactions to the contrast medium. 
PTC is performed primarily in patients 
in whom ERCP has failed, or when 
altered anatomy precludes access to the 
ampulla, and for biliary drainage and 




This technique uses a small high-frequency 
ultrasound probe mounted on the tip of 
an endoscope that is positioned in the 
duodenum by direct vision.  The close 
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Fig. 4. An ERCP demonstrating a malignant 
distal CBD stricture (arrow) secondary to a 
pancreatic carcinoma.
Fig. 5. ERCP basket extraction of CBD stone 
(arrow).
Fig. 6. Endoscopic plastic transpapillary bili-
ary stent (arrow).
Fig. 3. MRCP showing bile ducts obstructed 
by a hilar cholangiocarcinoma(upper arrow) 
and incidental gallstones in the gallbladder 
(lower arrow).
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proximity of the probe to the bile ducts 
and pancreas permits high-resolution 
imaging.  Several features make EUS a 
very useful procedure.  EUS is less invasive 
than ERCP, is able to identify most 
causes of obstructive jaundice such as 
pancreaticobiliary malignancies and CBD 
stones with similar or better accuracy than 
ERCP (Fig. 8), and does not expose the 
patient to radiation or contrast material.
Tissue sampling in the form of EUS-guided 
fine-needle aspiration can also provide 
a cytological diagnosis and important 
staging information in pancreaticobiliary 
malignancies.  The limitations of EUS 
include high operator dependency with a 
steep learning curve, equipment cost and 
availability, the inability to provide any 
immediate therapeutic procedure and the 
need for conscious sedation.  Visualisation 
is limited to within 8 cm from the probe, 
and imaging can be obscured by stents, 
surgical clips or calcific pancreatitis.
Applying further 
imaging in obstructive 
jaundice
If US demonstrates dilated intrahepatic 
bile ducts and a hilar tumour is suspected, 
MRCP is the next investigation of choice, 
as more accurate non-invasive imaging 
of the level and extent of the bile duct 
obstruction is obtained (Fig. 1). CT 
scanning is complementary to US and 
provides information on liver parenchyma, 
gallbladder pathology, bile duct dilatation 
and pancreatic disease.  CT is particularly 
valuable for the recognition of lesions 
as small as 1 cm in either the liver or 
the pancreas.  If further non-operative 
intervention is necessary to define the 
extent more accurately or relieve biliary 
obstruction, either ERCP or PTC are the 
second-line procedures used.  ERCP is 
advisable when the obstruction involves 
the lower common bile duct such as with 
gallstones or carcinoma of the head of 
the pancreas.  PTC is preferred for high 
obstructions (hilar cholangiocarcinoma or 
strictures of the hepatic duct bifurcation) 
because of better biliary opacification 
above the obstruction and a lower risk of 
introducing sepsis.
In most patients, a low obstruction of 
the CBD is drained endoscopically by 
ERCP, either by sphincterotomy and stone 
removal, or by inserting an intraluminal 
transpapillary biliary stent.  A stent may 
be the definitive treatment for inoperable 
carcinomas or in frail patients with large 
CBD stones.  For patients who have biliary 
infection and who require surgery, stenting 
provides effective preoperative biliary 
drainage by allowing the infection and 
jaundice to resolve and liver function to 
recover.  In patients who have irresectable 
hilar cholangiocarcinoma, expandable 
metal biliary stents provide effective 
palliation.  Percutaneous US-guided liver 
biopsy may be required to determine 
the nature and histological stage of 
intrinsic parenchymal liver disease, while 
laparoscopy with US is used in selected 
patients to assess and stage liver, biliary or 
pancreatic tumours before resection.  
In a nutshell 
•    Cholestatic jaundice caused by intrahepatic hepatocellular disease may be clinically and biochemically indistinguishable from 
cholestasis due to extrahepatic bile duct obstruction.
•    The most common intrahepatic causes of jaundice are viral hepatitis, alcohol-induced hepatitis, cirrhosis and drug-induced jaundice.  
•    Extrahepatic jaundice is most often due to a stone in the common bile duct or a pancreaticobiliary malignancy.  Pancreatic pseudocysts, 
chronic pancreatitis, sclerosing cholangitis, benign bile duct strictures or parasites in the bile duct are less common causes.
•    Ultrasound is a useful initial investigation because it is non-invasive and assesses pancreaticobiliary structures in real-time without 
exposing the patient to ionising radiation.
•    Dilated ducts are indirect evidence of biliary obstruction.  
•    If bile ducts are not dilated, hepatocellular disease is the likely diagnosis; however, parenchymal liver disease or sclerosing cholangitis 
may prevent biliary dilatation despite obstruction being present.
O bstruc tive jaundice
Fig. 7. PTC showing a hilar cholangiocarci-
noma (arrow).
Fig. 8. Endoscopic ultrasound showing a 
gallstone in the CBD.
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